30 closest matches · ranked by relevance
Pulmonary Lesions · Pulmonary Nodules · Pulmonary Mass
Primary: Diagnostic Yield of Procedures; Number of Positive Diagnosis of Pulmonary Lesions — 51; 62; 58; 51 participants
Lung; Node
Primary: Number of Participants With Device or Procedure Related Adverse Events — 2 Participants
Cancer
Primary: Sensitivity — 0.28; 0.72; 0.78; 1.33 # vascular sites detected per patient
Neoplasms, Pulmonary · Thoracic Diseases
Primary: Surgical Grading for Lung Isolation — 12; 13; 15; 14 participants
Inhalation Injury · Pneumonitis · Pneumonia
Primary: All Cause Mortality — 0; 1 participants
Other Surgical Procedures
Primary: Number of Participants With Fiberoptic Use During Surgeries Requiring Lung Isolation — 42; 5 Participants — p=<0.0001
Flexible Bronchoscopy
Primary: The Number of Participants With Any Hypoxemia Event During Flexible Bronchoscopy — 97; 88 participants — p=0.05
Bronchoscopy
Primary: Lowest Intraoperative Peripheral Oxygen Saturation (SpO2) — 94.7; 98.7 percentage of oxygen — p=0.09
Conscious Sedation Failure During Procedure
Primary: Change in Transcutaneous CO2 Pressure — 43.6; 45.6 Unit of Measure "mmHg" — p=0.281
Intubation; Difficult
Primary: Time Until Proper Endotracheal Tube Placement — 49; 64 seconds
Lung Diseases · Ultrasonography · Fiberoptic Bronchoscopy
Primary: Number of Patients of Lung Collapse in Ultrasonography and Fiberoptic Bronchoscopy — 89; 83 Participants
Lung Diseases
Primary: Number of Participants With Serious Adverse Events — 0 Participants
Bronchoscopy · Anesthesia
Primary: User Preference of Scope — 103; 37; 35 Participants
Peripheral Pulmonary Nodules
Primary: Feasibility — 24 participants
Sedation, Bronchoscopy
Primary: Discharge Assessment Using PADSS After 2 Hours Number of Patients Reaching PADSS Score 10 After 2 Hours — 19; 30; 45 Participants
Bronchoscopy
Primary: Number of Participants With a Successful Procedure — 250; 3; 24 Participants — p=<0.0001
Lung Nodule
Primary: Diagnostic Accuracy — 94; 81 Participants — p=0.003
Lung Cancer
Primary: The Difference of Diagnostic Value of ENB-GS-TBLB as Compared to GS-TBLB — 34; 25; 5; 16 participants — p=0.019
Bronchi--Diseases · Lung Diseases, Obstructive · Lesions Mass
Primary: Ability to Successfully Obtain Sample — 123; 130 tissue samples
Pulmonary Disease
Primary: Time to Achieve Hemostasis After Obtaining Cryobiopsy — 146.55; 132.25 seconds — p=0.7878
Sedation
Primary: Decreased Minute Ventilation — 0.736; 0.764 percentage of baseline — p=<0.0001
Peripheral Pulmonary Lesions
Primary: Diagnostic Yield — 157; 158 Participants
Pulmonary Infiltrate New
Primary: Number of Patients With Positive Culture or Molecular Results After Brochoscopy — 40 participants
Non-small Cell Lung Cancer (NSCLC) · Lung Metastasis
Primary: Feasibility to Perform Interstitial-Photodynamic Therapy (i-PDT) Into Tumor — 3; 0; 1; 1 Participants
Video-assisted Thoracoscopic Surgery · Lung Isolation Device · One-lung Ventilation
Primary: Time to Obtain Complete Lung Collapse — 47.8; 32.5 minutes
Lung Lesion(s) Requiring Evaluation
Primary: Incidence of Pneumothorax (Grade 2+) — 44 Participants
Intubation, Intratracheal
Primary: Modified Intubation Difficulty Scale Score (mIDS) — 1; 0 score on a scale range of 0 to 10 number
Double Lumen Endotracheal Tube · Single Lung Ventilation
Primary: Number of Participants Requiring Flexible Fiberoptic Bronchoscopy — 25; 7 Participants
Cigarette Smoker · Current Every Day Smoker
Primary: Changes in Cytokines — 0.2473; -0.04988; -0.1137; -0.05875 pg/ml
Non Small Cell Lung Cancer · NSCLC
Primary: Feasibility of Utilizing Endobronchial Ultrasound Guided Miniforceps as Assessed by the Number of Participants From Whom Adequate Amounts of Tissue to Perform PD-L1…